Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Epizyme Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Epizyme Inc (EPZM-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

23 Aug 2016 Thomson Reuters Stock Report 12 $25.00

EPIZYME INC (EPZM=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

20 Aug 2016 Pechala's Reports 2 $25.00

Value Graph: EPIZYME -- EPZM

19 Aug 2016 Ford Investor Services, Inc. 1 $12.00

EpiZyme, Inc. (EPZM) - Financial Analysis Review

EpiZyme, Inc. (EPZM) - Financial Analysis Review Summary EpiZyme, Inc. (Epizyme) is a clinical stage biopharmaceutical compan...

17 Aug 2016 GlobalData 56 $300.00

ValuEngine Rating and Forecast Report for EPZM

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

14 Aug 2016 ValuEngine, Inc. 11 $25.00

EPZM.OQ - Event Transcript of Epizyme Inc conference call, Aug. 08, 2016 / 8:30AM ET

Edited Event Transcript of EPZM.OQ conference call, Aug. 08, 2016 / 8:30AM ET Boston, Aug 8, 2016 (Thomson StreetEvents...

08 Aug 2016 Thomson Reuters StreetEvents 14 $75.00

Wright Investors Service Comprehensive Report for Epizyme Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

28 Jul 2016 Wright Reports 60 $75.00

EpiZyme, Inc. (EPZM) - Financial Analysis Review

EpiZyme, Inc. (EPZM) - Financial Analysis Review Summary EpiZyme, Inc. (Epizyme) is a clinical stage biopharmaceutical compan...

16 Jun 2016 GlobalData 53 $300.00

Thomson Reuters Stock Report - Epizyme Inc (EPZM-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 12 $25.00